Oxaliplatin
Showing 1 - 25 of 2,535
Immunotherapy Gastrict Cancer Trial (Tislelizumab, apatinib, oxaliplatin)
Not yet recruiting
- Immunotherapy Gastrict Cancer
- Tislelizumab
- +3 more
- (no location specified)
Jan 17, 2023
Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Oxaliplatin; Capecitabine, Oxaliplatin; Capecitabine; concurrent
Completed
- Gastroesophageal Junction Adenocarcinoma
- Oxaliplatin; Capecitabine
- Oxaliplatin; Capecitabine; concurrent radiotherapy
-
Shijiazhuang, Hebei, ChinaDepartment of General Surgery
Feb 4, 2022
Neuropathy;Peripheral Trial in Tanta (Placebo tablets, Ketotifen Oral Tablet)
Not yet recruiting
- Neuropathy;Peripheral
- Placebo tablets
- Ketotifen Oral Tablet
-
Tanta, EgyptTanta university
Nov 23, 2022
Chemo Induced Peripheral Neuropathy Trial (Omeprazole)
Not yet recruiting
- Chemotherapy Induced Peripheral Neuropathy
- (no location specified)
Jan 10, 2023
Hepatocellular Carcinoma Trial in Guangzhou (Raltitrexed, oxaliplatin (SALOX) treatment, Oxaliplatin, fluorouracil/leucovorin
Recruiting
- Hepatocellular Carcinoma
- Raltitrexed, oxaliplatin (SALOX) treatment
- Oxaliplatin, fluorouracil/leucovorin (FOLFOX) treatment
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
May 17, 2022
Elderly Metastatic Colorectal Cancer Patients Trial in Padua (Capecitabine, Oxaliplatin, Bevacizumab)
Active, not recruiting
- Elderly Metastatic Colorectal Cancer Patients
- Capecitabine
- +2 more
-
Padua, ItalyIstituto Oncologico Veneto IRCCS
Mar 30, 2022
Advanced Colorectal Cancer Trial (Bevacizumab combined with Oxaliplatin and TAS-102)
Not yet recruiting
- Advanced Colorectal Cancer
- Bevacizumab combined with Oxaliplatin and TAS-102
- (no location specified)
May 16, 2022
Gastric Cancer Trial in Gyeonggi-do (Oxaliplatin, Capecitabine)
Recruiting
- Gastric Cancer
- Oxaliplatin
- Capecitabine
-
Gyeonggi-do, Korea, Republic ofHallym University Medical Center
Feb 4, 2022
Locally Advanced Gastric Carcinoma Trial in Hanzhou (Oxaliplatin by arterial infusion plus S-1, SOX neoadjuvant, gastrectomy
Not yet recruiting
- Locally Advanced Gastric Carcinoma
- Oxaliplatin by arterial infusion plus S-1
- +3 more
-
Hanzhou, Zhejiang, ChinaGastrointestinal Department of Second Affiliated Hospital of Zhe
Oct 20, 2022
Gastric Cancer Trial in Xi'an (Nab-paclitaxel combined with oxaliplatin and S-1)
Recruiting
- Gastric Cancer
- Nab-paclitaxel combined with oxaliplatin and S-1
-
Xi'an, ChinaThe First Affiliated Hospital of the Air Force Medical Universit
Jul 13, 2022
Stage III Colon Cancer Trial in France (Oxaliplatin, Oxaliplatin LBM)
Active, not recruiting
- Stage III Colon Cancer
- Oxaliplatin
- Oxaliplatin LBM
-
Marseille, Bouches Du Rhône, France
- +10 more
Aug 2, 2022
Peripheral Neuropathy, Colorectal Cancer Trial in Vejle (Fish oil, Corn oil)
Recruiting
- Peripheral Neuropathy
- Colorectal Cancer
- Fish oil
- Corn oil
-
Vejle, DenmarkDeparment of Oncology, Vejle Hospital
Aug 8, 2022
Gastric Cancer Trial in Beijing (S-1, Trastuzumab, Oxaliplatin)
Completed
- Gastric Cancer
- S-1
- +3 more
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences
Aug 14, 2022
Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)
Terminated
- Colorectal Neoplasms
- bevacizumab
- +3 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Dec 30, 2021
Gastric Cancer Trial in Mykolaiv (Docetaxel, Oxaliplatin, Leucovorin)
Active, not recruiting
- Gastric Cancer
- Docetaxel
- +4 more
-
Mykolaiv, UkraineUkrainian Society of Clinical Oncology
Apr 11, 2022
Oncology Trial (Duloxetine, Gabapentin, Lacosamide)
Not yet recruiting
- Oncology
- Duloxetine
- +2 more
- (no location specified)
Aug 19, 2022
Advanced Biliary Tract Carcinoma Trial in Hangzhou (Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur)
Not yet recruiting
- Advanced Biliary Tract Carcinoma
- Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur
-
Hangzhou, Zhejiang, Chinathe First Affiliated Hospital, School of Medicine, Zhejiang Univ
Jul 6, 2022
Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)
Not yet recruiting
- Gastric Cancer Stage IV
- Oxaliplatin
- +4 more
- (no location specified)
Apr 1, 2022
Immunotherapy, Gastrict Cancer Trial in Fuzhou (Tislelizumab, Apatinib Mesylate, oxaliplatin)
Recruiting
- Immunotherapy
- Gastrict Cancer
- Tislelizumab
- +3 more
-
Fuzhou, ChinaFujian cancer hospital
Jan 23, 2022
Gastric Cancer, Gastric Adenocarcinoma, Effects of Chemo Trial in Taiwan (leucovorin, oxaliplatin, docetaxel, S-1)
Recruiting
- Gastric Cancer
- +3 more
- leucovorin, oxaliplatin, docetaxel, S-1
-
Kaohsiung, Taiwan
- +3 more
May 24, 2022
Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo
Not yet recruiting
- Colorectal Adenocarcinoma
- +2 more
- Nivolumab
- Oxaliplatin
-
Trondheim, Trondelag, Norway
- +2 more
Aug 15, 2022
Rectal Cancer, Consolidation Trial in São Paulo (Oxaliplatin, 5FU)
Recruiting
- Rectal Cancer
- Consolidation
- Oxaliplatin
- 5FU
-
São Paulo, SP, BrazilHospital Alemão Oswaldo Cruz
Aug 3, 2021
Metastatic Colorectal Cancer Trial in Herlev (Oxaliplatin, 5-Fluorouracil, Leucovorin)
Withdrawn
- Metastatic Colorectal Cancer
- Oxaliplatin
- +4 more
-
Herlev, DenmarkHerlev University Hospital, Department of Oncology
Oct 19, 2021
Colon Adenocarcinoma Trial in Sacramento (Carbon C 14 Oxaliplatin, Oxaliplatin)
Completed
- Colon Adenocarcinoma
- Carbon C 14 Oxaliplatin
- Oxaliplatin
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Mar 4, 2021